Challenges of developing a bioanalytical method for a macrolide immunosuppressant compound by LC-MS/MS

Bioanalysis

Volumn 3, Issue 11, 2011, Pages 1201-1215

  Taillon, Marie Pierre ^a   Furtado, Milton ^a   Garofolo, Fabio ^a  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ASCOMYCIN; EVEROLIMUS; TACROLIMUS;

ACCURACY; ANALYTIC METHOD; ANALYTICAL EQUIPMENT; ARTICLE; CONCENTRATION (PARAMETERS); DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; DRUG STABILITY; DRUG STRUCTURE; ERYTHROCYTE; FRAGMENTATION REACTION; FREEZE THAWING; HUMAN; IONIZATION; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; PRECIPITATION; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; ULTRASOUND;

ARTIFACTS; BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, LIQUID; EQUIPMENT FAILURE; FREEZING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIMIT OF DETECTION; TACROLIMUS; TANDEM MASS SPECTROMETRY;

EID: 79958696966     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.93     Document Type: Article

References (25)

1. Sawada S, Suzuki G, Kawase Y, Takaku F. Novel immunosuppressive agent, FK506 - in vitro effects on the cloned T cell activation. J. Immunol. 139, 1797-1803 (1987).
2. Shaw LM. Advances in cyclosporine pharmacology, measurement, and therapeutic monitoring. Clin. Chem. 35(7), 1299-1308 (1989). (Pubitemid 19187808)
3. Starzl TE, Todo S, Fung J, Demetris AJ, Venkstaramman R, Ashak J. FK506 for liver, kidney, and pancreas transplantation. Lancet 2, 1000-1004 1989). (Pubitemid 19257914)
4. Jusko WJ, D'Ambrosie R. Monitoring FK-506 concentrations in plasma and whole blood. Transplant. Proc. 23, 2732-2735 (1991).
5. Beysens AJ, Wijnen RMH, Beuman GH et al. Monitoring in plasma or whole blood. Transplant. Proc. 23, 2745-2747 (1991).
6. Sewing KF, Christians U. FK 506. Lancet, 337-499 (1991)
7. Friob MC, Hassoun A, Latinne D, Lhoëst G, Otte JB, Wallemacq PE. A combined HPLC-ELISA evaluation of FK 506 in transplant patients. Transplant. Proc. 23, 2750-2752 (1991).
8. Salm P, Taylor PJ, Pillans PI. Analytical performance of microparticle enzyme immunoassay and HPLC-tandem mass spectrometry in the determination of sirolimus in whole blood. Clin. Chem. 45(12), 2278-2280 (1999).
9. Alak AM. Measurement of tacrolimus (FK506) and its metabolites, a review of assay development and application in therapeutic drug monitoring and pharmacokinetic studies. Ther. Drug. Monit. 19, 338 (1997).
10. Winkler M, Christians U, Stoll K, Baumann J, Pichlmayr R. Comparison of different assays for the quantitation of FK 506 levels in blood or plasma. Ther. Drug. Monit. 16, 281-286 (1994). (Pubitemid 24166988)
11. Gonschior A-K, Christians U, Braun F et al. Measurement of blood concentrations of FK506 (tacrolimus) and its metabolites in seven liver graft patients after the first dose by HPLC-MS and microparticle enzyme immunoassay (MEIA). Br. J. Clin. Pharmacol. 38, 567-571 (1994). (Pubitemid 24365865)
12. Gonschior A-K, Christians U, Winkler M, Schiebel HM, Linck A, Sewing K-FR. Simplified high-performance liquid chromatography-mass spectrometry assay for measurement of tacrolimus and its metabolites and cross-validation with microparticle enzyme immunoassay. Ther. Drug. Monit. 17(5), 504-510 (1995).
13. Streit F, Armstrong VW, Oellerich M. Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination or sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood. Clin. Chem. 48(6), 955-958 (2002). (Pubitemid 34587603)
14. Chen Y-L, Hirabayashi H, Akhtar S, Pelzer M, Kobayashi M. Simultaneous determination of three isomeric metabolites of tacrolimus (FK506) in human whole blood and plasma using high performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B. 803, 330-341 (2006). (Pubitemid 43075470)
15. Vogeser M. Instrument-specific matrix effects of calibration materials in the LC-MS/MS analysis of tacrolimus. Clin. Chem. 54(8), 1406-1408 (2008).
16. US FDA. Code of Federal Regulations of the Food and Drug Administration 21. Part 58 Good Laboratory Practice for Nonclinical Laboratory Studies. US FDA, MD, USA (2001).
17. Zhang Q, Simpson J, Aboleneen HI. A specific method for the measurement of tacrolimus in human whole blood by liquid chromatography/tandem mass spectrometry. Ther. Drug. Monit. 19(4), 470-476 (1997). (Pubitemid 28074046)
18. Bonfiglio R, King RC, Olah TV, Merkle K. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun. Mass Spectrom. 13, 1175-1185 (1999). (Pubitemid 29285118)
19. Morin L-P, Taillon M-P, Mess J-N et al. The use of hybrid triple quadrupole linear ion trap mass spectrometer to resolve high chemical noise in the tacrolimus assay. Presented at: The 58th ASMS Conference on Mass Spectrometry and Allied Topics. Salt Lake City, UT, USA 23-27 May 2010.
20. Mess J-N, Morin L-P, Ramagiri S et al. Application of a high resolution quadrupole time-of-flight mass spectrometer to resolve chemical noise in regulated bioanalysis. Presented at: The 59th ASMS Conference on Mass Spectrometry and Allied Topics. Denver, CO, USA 5-9 June 2011.
21. US Food and Drug Administration. Guidance for Industry: Bioanalytical Method Validation. US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research, Rockville, MD, USA (2001).
22. Viswanathan CT, Bansal S, Booth B et al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Workshop/Conference Report. AAPS J.9(1), E30-E42 (2007). (Pubitemid 46296546)
23. Savoie N, Booth BP, Bradley T et al. 2008 White Paper: The 2nd Calibration and validation group workshop on recent issues in good laboratory practice bioanalysis. Bioanalysis 1(1), 19-30 (2009).
24. Savoie N, Garofolo F, van Amsterdam P et al. 2009 White paper on recent issues in regulated bioanalysis from the 3rd calibration and validation group workshop. Bioanalysis 2(1), 53-68 (2010).
25. Savoie N, Garofolo F, van Amsterdam P et al. 2010 White paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidance, Bioanalysis 2(12), 1945-1960 (2010).